Xiamen Amoytop Biotech Co., Ltd. Class ASSE: 688278

"Xiamen Amoytop Biotech Co., Ltd."Announcement on Participating in the 2026 Semi-annual Collective Performance Briefing for the STAR Market Innovative Drug Industry

Sep 8, 2026 · Issued by Xiamen Amoytop Biotech Co., Ltd. Class A via Shanghai Stock Exchange

Announcement on Participating in the 2026 Semi-annual Collective Performance Briefing for the STAR Market Innovative Drug Industry

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Company analysis

Earlier from Xiamen Amoytop Biotech Co., Ltd. Class A

"Xiamen Amoytop Biotech Co., Ltd."Announcement on Use of Funds Raised from Convertible Corporate Bonds to Replace Self-raised Funds Previously Invested in Raised Funds Investment Projects and Paid Issuance ExpensesAug 19
"Xiamen Amoytop Biotech Co., Ltd."Announcement on Opening a Special Account for Raised Funds and Signing a Tripartite Supervision Agreement for Deposit of Raised Funds in Special AccountAug 14
"Xiamen Amoytop Biotech Co., Ltd."Announcement on Listing of Convertible Corporate Bonds Issued to Unspecified InvestorsAug 11

All Xiamen Amoytop Biotech Co., Ltd. Class A news releases